Delicate Balances in Cancer Chemotherapy: Modeling Immune Recruitment and Emergence of Systemic Drug Resistance

doi 10.1101/2019.12.12.874891
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

The Role of P53 in Cancer Drug Resistance and Targeted Chemotherapy

Oncotarget
Oncology
2016English

Drug Resistance in Cancer Therapy

Drug Delivery and Translational Research
Pharmaceutical Science
2011English

Drug Resistance in Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2010English

Pharmacogenomic Modeling of Circulating Tumor and Invasive Cells for Prediction of Chemotherapy Response and Resistance in Pancreatic Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

WNT Signaling and Drug Resistance in Cancer

Molecular Pharmacology
Molecular MedicinePharmacology
2019English

Acquired Resistance to Cancer Chemotherapy.

BMJ
1984English

Improved Chemotherapy Modeling With RAG-based Immune Deficient Mice

PLoS ONE
Multidisciplinary
2019English

Nuclear Export of Proteins and Drug Resistance in Cancer

Biochemical Pharmacology
BiochemistryPharmacology
2012English

Liposome Drug Delivery in Cancer Chemotherapy: Review and Multifactorial Analysis

JOURNAL OF BIOENGINEERING OF AND TECCHNOLOGY applied to Health
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy